Pidilite Industries Ltd shares were down over 1% in Friday’s session, trading near ₹1,470 on October 31, after the company posted its September quarter (Q2) earnings. Investors reacted cautiously despite steady revenue and profit growth, as performance remained broadly stable amid a challenging macro backdrop.

Q2 FY25 Performance: Profit up 8.2% YoY, revenue rises nearly 10%

Pidilite, known for brands like Fevicol, Feviquick and Dr. Fixit, reported an 8.2% year-on-year increase in consolidated net profit at ₹584.6 crore for the July–September quarter, compared to ₹540.3 crore in the same period last year. Revenue rose 9.9% YoY to ₹3,554 crore from ₹3,235 crore, supported by healthy demand across consumer and construction solutions segments.

The company delivered strong operating performance, with EBITDA up 10.5% YoY to ₹850 crore. Operating margin remained stable at 23.9%, marginally higher than 23.8% in the year-ago quarter.

Management commentary: Demand outlook positive

Managing Director Sudhanshu Vats said the company delivered double-digit underlying volume growth, sequential improvement, and healthy margins despite macroeconomic uncertainties. He noted that demand recovery is expected to be supported by favourable monsoons, benefits from GST 2.0, and strong construction sector activity.

“The domestic operating environment is expected to improve,” Vats said, while highlighting the need to stay cautious amid global uncertainties that may impact supply chains.

Stock update

Pidilite shares traded around ₹1,470, down over 1.02% on Friday. The stock has been moving between ₹1,465 and ₹1,490 during the session, with a market cap of ₹1.51 lakh crore. The counter has a 52-week range of ₹1,310.08 to ₹1,620.10.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.